Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anticoagulants in the elderly. Indications].

A Gentric1, F Couturaud, D Mottier

  • 1Service de Médecine interne gériatrique, Hôptital de la Cavale Blanche, Brest.

Presse Medicale (Paris, France : 1983)
|July 4, 2001
PubMed
Summary

Anticoagulant therapy benefits are proven, but elderly patients require careful risk-benefit assessment due to higher bleeding risks. New approaches aim to improve safety and efficacy in this population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same author

[Imaging tests for the diagnosis of dyspnea during pregnancy].

Revue des maladies respiratoires·2025
Same author

[Translation into French and republication of: "Recurrent venous thromboembolism in anticoagulated cancer patients: diagnosis and treatment"].

La Revue de medecine interne·2024
Same author

[Translation into French and republication of: "Management of cancer-associated thromboembolism in vulnerable population"].

La Revue de medecine interne·2024
Same author

[Translation into French and republication of: "Anticoagulant treatment of cancer-associated thromboembolism"].

La Revue de medecine interne·2024
Same author

[Approaching patient experience following pulmonary embolism: A systematic review].

Revue des maladies respiratoires·2023

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Clinical Trials

Context:

  • Anticoagulant treatments are established for venous thromboembolism and atrial fibrillation in specific populations.
  • Limited clinical trials focus on elderly subjects, who face increased thrombosis and bleeding risks.
  • Extrapolating data from younger populations to the elderly is unreliable due to physiological differences.

Purpose:

  • To emphasize the need for individualized risk-benefit assessments in elderly patients undergoing anticoagulant therapy.
  • To highlight the inadequacy of current data for guiding anticoagulant use in geriatric populations.
  • To advocate for tailored evaluation systems for elderly individuals to optimize treatment decisions and minimize hemorrhage risk.

Summary:

  • Established anticoagulant treatments have proven benefits but require careful consideration in elderly patients.
  • Elderly individuals exhibit a higher risk of both thrombosis and bleeding complications from anticoagulation.
  • Individualized risk-benefit evaluations using geriatric-specific assessment tools are crucial for safe and effective anticoagulation in older adults.

Impact:

  • Promotes the development of specialized anticoagulation clinics and geriatric-focused clinical trials.
  • Encourages the creation of new oral anticoagulants with simplified monitoring requirements for the elderly.
  • Aims to reduce therapeutic risks while maintaining or improving anticoagulant benefits in the geriatric population.

Related Experiment Videos